Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor

Lignende værker

• Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic Effect
  af: Koka, Saisudha, et al.
  Udgivet: (2010)
• Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling
  af: Koka, Saisudha, et al.
  Udgivet: (2014)
• Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury
  af: Ahmad, Nauman, et al.
  Udgivet: (2009)
• Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases
  af: Kukreja, Rakesh C, et al.
  Udgivet: (2011)
• Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report
  af: Sakamoto, Mito, et al.
  Udgivet: (2016)